Chronic cyclosporine nephrotoxicity

被引：81

作者：

Andoh, TF ^{[1
]}

Bennett, WM ^{[1
]}

机构：

[1] Oregon Hlth Sci Univ, Dept Med, Div Nephrol Hypertens & Clin Pharmacol, Portland, OR 97201 USA

来源：

CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION | 1998年 / 7卷 / 03期

关键词：

D O I：

10.1097/00041552-199805000-00005

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Cyclosporine has improved patient and graft survival rates in solid organ transplantation, and has been increasingly applied with considerable clinical benefit in the treatment of autoimmune diseases. However, the therapeutic benefits of immunosuppressive therapy for transplant and autoimmune indications have frequently been limited by the occurrence of chronic nephrotoxicity. Cyclosporine nephrotoxicity therefore remains an important clinical challenge. The clinical aspects and pathophysiology of chronic cyclosporine nephrotoxicity, which is characterized by a decrease in glomerular filtration rate, afferent arteriolopathy, and striped tubulointerstitial fibrosis, are reviewed. Insights gained from experimental models of chronic nephrotoxicity associated with tubulointerstitial fibrosis are presented to elucidate the pathophysiology. (C) 1998 Rapid Science Ltd.

引用

页码：265 / 270

页数：6

共 26 条

[1] Decrease in kidney calbindin-D 28kDa as a possible mechanism mediating cyclosporine A- and FK-506-induced calciuria and tubular mineralization [J].

Aicher, L ;

Meier, G ;

Norcross, AJ ;

Jakubowski, J ;

Varela, MD ;

Cordier, A ;

Steiner, S .

BIOCHEMICAL PHARMACOLOGY, 1997, 53 (05) :723-731

[2] Protective effects of dietary L-arginine supplementation on chronic cyclosporine nephrotoxicity [J].

Andoh, TF ;

Gardner, MP ;

Bennett, WM .

TRANSPLANTATION, 1997, 64 (09) :1236-1240

[3]

Andoh TF, 1997, SEMIN NEPHROL, V17, P34

[4] Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506 [J].

Andoh, TF ;

Burdmann, EA ;

Fransechini, N ;

Houghton, DC ;

Bennett, WM .

KIDNEY INTERNATIONAL, 1996, 50 (04) :1110-1117

[5] Synergistic effects of cyclosporine and rapamycin in a chronic nephrotoxicity model [J].

Andoh, TF ;

Lindsley, J ;

Franceschini, N ;

Bennett, WM .

TRANSPLANTATION, 1996, 62 (03) :311-316

[6] Enhancement of chronic cyclosporine nephrotoxicity by sodium depletion in an experimental mouse model [J].

Andoh, TF ;

Lam, TT ;

Lindsley, J ;

Alpers, CE ;

Bennett, WM .

NEPHROLOGY, 1997, 3 (05) :471-478

[7] L-arginine and allopurinol protect against cyclosporine nephrotoxicity [J].

Assis, SM ;

Monteiro, JL ;

Seguro, AC .

TRANSPLANTATION, 1997, 63 (08) :1070-1073

[8] Effect of cilastatin on cyclosporine-induced acute nephrotoxicity in kidney transplant recipients [J].

Carmellini, M ;

Frosini, F ;

Filipponi, F ;

Boggi, U ;

Mosca, F .

TRANSPLANTATION, 1997, 64 (01) :164-166

[9] Cyclosporine-associated end-stage nephropathy after cardiac transplantation - Incidence and progression [J].

Goldstein, DJ ;

Zuech, N ;

Sehgal, V ;

Weinberg, AD ;

Drusin, R ;

Cohen, D .

TRANSPLANTATION, 1997, 63 (05) :664-668

[10] Cyclosporine-induced hypertension and decline in renal function in healthy volunteers [J].

Hansen, JM ;

FoghAndersen, N ;

Christensen, NJ ;

Strandgaard, S .

JOURNAL OF HYPERTENSION, 1997, 15 (03) :319-326

← 1 2 3 →